bella roma deli cafe, inc.

53 main street
tarrytown, new york 10591

NYS Entity Status
ACTIVE

NYS Filing Date
JANUARY 16, 2014

NYS DOS ID#
4514533

County
WESTCHESTER

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2014 - BELLA ROMA DELI CAFE, INC.









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Restaurant Review: At Atla, Mexican for Every Moment of the Day
    By PETE WELLS - Tuesday Jul 25, 2017

    From the chefs behind Cosme, a more casual cafe whose food you may want to eat every day.

    Source: NYT > Home Page
  • View From the River Café: 40 Years of Feasts and Firsts
    By BRYAN MILLER - Monday Jul 31, 2017

    This special-occasion restaurant on the East River in Brooklyn was in many ways a pioneer, yet its understated charm and elegant owner still thrive.

    Source: NYT > Home Page
  • Grace Notes: Atop a Manhattan Convention Center, a Harvest of Honey
    By JAMES BARRON - Sunday Sep 10, 2017

    Beehives on the Javits Center’s roof are yielding their first batches of honey, which will go into dressing on salads sold in a center cafe.

    Source: NYT > Home Page
  • Bella Thorne's steamy pics
    By foxnewsonline@foxnews.com (Fox News Online) - Thursday Jul 20, 2017

    Source: Fox News
  • Bellas bare all
    By foxnewsonline@foxnews.com (Fox News Online) - Tuesday Aug 29, 2017

    Source: Fox News
  • Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing
    By Ben Fidler - Monday Sep 11, 2017

    A new drug for patients who have a hard time controlling their asthma could be nearing an FDA review. Tarrytown, NY-based Regeneron Pharmaceuticals (NASDAQ: REGN) and partner Sanofi this morning are touting results this morning from a 1,902-patient Phase 3 study called Liberty Asthma Quest. In it, their injectable antibody drug dupilumab (Dupixent), already approved […]

    Source: Xconomy New York